REGISTERED
on 11 Feb 2020
Last Applicant/ Owned by
CH-8820 Wädenswil
CH
Serial Number
79250615 filed on 03rd Dec 2018
Registration Number
5980170 registered on 11th Feb 2020
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
LAMBDA-CAP
Research and development in the field of pharmaceutical products, biotechnology, antibodies and antibody fragments, proteins, micro-organisms and cells for therapeutic purposes; research with respect to pharmaceutical products, biotechnology, therapy, antibody and gene therapy; research, product development and quality control in the field of pharmacy, diagnostics and therapy; research in the fiel Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development in the field of pharmaceutical products, biotechnology, antibodies and antibody fragments, proteins, micro-organisms and cells for therapeutic purposes; research with respect to pharmaceutical products, biotechnology, therapy, antibody and gene therapy; research, product development and quality control in the field of pharmacy, diagnostics and therapy; research in the field of chemistry and biology; industrial analysis and research services in the field of biochemistry and pharmaceuticals; research and development of antibody products for therapeutic purposes; preparing and conducting chemical, biochemical and biotechnological analysis and research
Class [005]
Pharmaceutical Products
Pharmaceutical and veterinary products, namely, pharmaceutical products for the prevention and treatment of immune system related diseases and disorders, therapeutic vaccines; pharmaceutical preparations, namely, pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases; medicines for human medicine, namely, medicinal preparations for the treatment of infectious diseases and for use in oncology; chemical pharmaceutical products for the diagnosis and treatment of cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases; diagnostic preparations for medical use; chemical preparations for pharmaceutical use namely, for diagnosing and treating cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases
Class [001]
Chemical Products
Chemical, biochemical, biological and biotechnological products intended for industry and science, namely, biological preparations for use in industry and science, diagnostic preparations for clinical and medical laboratory use; chemical, biochemical, biological and biotechnological products, namely, antibodies and antibody particles for development and manufacture of pharmaceutical products; biological products, namely, antibodies and antibody fragments for use in laboratories, diagnosis and analysis for scientific and research purposes; chemical and biochemical additives, supports and substances for the manufacture of pharmaceutical products
Mark Details
Serial Number
No 79250615
Mark Type
No Service Mark
Attorney Docket Number
No 2T19719656
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 31st Dec 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| 27th Aug 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| 20th Aug 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| 12th Jun 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 27th May 2020 | FINAL DISPOSITION PROCESSED |
| 27th May 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| 11th May 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 11th Feb 2020 | REGISTERED-PRINCIPAL REGISTER |
| 26th Nov 2019 | PUBLISHED FOR OPPOSITION |
| 26th Nov 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |